Clinical Updates | Public Health Policy and Practice Updates | January 13, 2021
Date of Presentation: January 13, 2021
In this series of presentations, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services shares the latest clinical updates on COVID-19. Then, Brigg Reilley, MPH, provides an overview of recent COVID-19 research, as well as a number of valuable COVID-19 related resources produced by the FDA and CDC.
Recording:
Presented by:
Dr. Jorge Mera, Whitney Essex, Brigg Reilley
Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Service, the largest tribally operated health care system in the United States. He oversees surveillance, policies, and programs to treat and prevent the transmission of COVID-19, sexually transmitted diseases, HIV and HCV.
Whitney Essex, MSN, FNP-BC, is a Family Nurse Practitioner for Cherokee Nation Health Services. Mrs. Essex works in the Infectious Diseases Department, where she is the coordinator for the Cherokee Nation Hepatitis C Elimination program. She assists in the maintenance of general infectious diseases clinical services, as well as the provision of medical care for patients accessing HIV, PrEP, Hepatitis C, and other infectious diseases-related services.
Brigg Reilley, MPH, is an Epidemiologist and Contractor for the Northwest Portland Area Indian Health Board. Mr Reilley provides support for the US Indian Health Service national HIV and hepatitis C virus (HCV) program. He has been working in American Indian/Alaska Native health since 2006. Prior to Indian Health Service, he worked for MSF for ten years in several emergency and non-emergency project settings, and served on the MSF Board of Directors from 2008-2011. He obtained a Masters in Public Health from Tulane University in 1996 and a BA in Philosophy from the College of William & Mary in 1990.
Resources Provided:
- Clinical Updates (Presentation Slides)
- Public Health Practice and Policy Updates (Presentation Slides)
- Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux? (NEJM Journal Watch)
- Ivermectin: potential candidate for the treatment of Covid 19 (Braz J Infect Dis)
- The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19 (ASCPT)
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults (NEJM)
- FAQs and Communication Resources for Wildland Firefighters (CDC)
- Improving Ventilation in Your Home (CDC)
- Staff to staff transmission as a driver of healthcare worker infections with COVID-19 (medRxiv)
- COVID-19 testing: One size does not fit all (Science)
- Use of Coronavirus Rapid Tests May Have Fueled White House Covid-19 Cluster, Experts Say (WSJ)
- Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions (JAMA)
- EUA Authorized Serology Test Performance (FDA)
- Mitigation Policies and COVID-19–Associated Mortality — 37 European Countries, January 23–June 30, 2020 (MMWR)
Date added: January 13, 2021